One Belt, One Road' - Pakistan Pharma Asia 2017
Pharma Asia 2017
Pharma Asia is a 3 day event being held from 22nd August to the 24th August 2017 at the Karachi Expo Center in Karachi, Pakistan. This event showcases products like providing investors with a definite outlook of the regional Pharmaceutical industry and an opportunity to meet their prospective counterparts and business partners etc. in the Medical & Pharmaceutical industry.
About ECHEMI
ECHEMI is a professional, high-efficiency and convenient chemical one-stop transaction service platform. Founded in July 2015, ECHEMI is a professional chemical B2B platform and provides distinctive professional export services to chemical producers. There are a large number of chemical experts and IT engineers in our company and we provide multilingual services. ECHEMI Platform provides transparent information of manufacturers and prices of various products. We aim to realize 50 billion RMB trading value and have 100,000 members and 10,000 kinds of products.
ECHEMI at Pharma Asia 2017
During August 22 to 24, ECHEMI will attend this exhibition with other four Chinese companies. And the Booth No. Is : B32, B60, B61, B82, B83. ECHEMI is looking forward to meeting you there!
2026-08-29
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
CPHI Korea 2026: A Leading Gateway to Korea’s Pharmaceutical and Biopharma Market
-
Pakistan Launches Successive Anti-dumping Investigations against Chinese Products, Involving Soda Ash, Ibuprofen and Other Raw Materials
-
Pharmaconex
-
Pharma Quality Excellence Awards 2026 - Celebration and Conclusion
-
Pharma Quality Reimagined: Highlights from the 6th Annual Pharma GMP & Quality Management 2026
-
From Feedmill to Food System: VIV Europe 2026 Addresses the Industry's Most Critical Challenges
-
Beyond Compliance: Building Quality Maturity
-
AkzoNobel's polyurethane coating factory opens in Pakistan
-
Is the class solidified? From Biotech to Pharma
-
The IPO of the Largest Domestic Metronidazole API Manufacturer has Passed the Meeting
Recommend Reading
-
US Imposes Heavy Duties on Chinese L-Lysine with Combined Rates up to 188%
-
Honeywell Acquires Johnson Matthey Catalyst Business at a Discount, Cutting £475 Million from the Price
-
The Capital Undercurrent in the Desert: China’s Banks, Saudi Gas, and the “Absent” Chinese Funds
-
When Soybeans Lose Weight, Fertilizers Take the Stage: The Industrial Chain Reaction Behind U.S. Farm Subsidies
-
Kemira to Acquire SIDRA Wasserchemie, Expanding European Water Treatment Footprint
-
Petroleum Coke Market for Local Refineries Drops Sharply in Late April
-
Business Society’s Diesel Market Outlook on August 17, 2026: Fluctuating Trends
-
Geopolitical Risks and Supply-Demand Changes Boost Crude Oil Prices Significantly During the Chinese New Year
-
Insufficient Support, Shandong Cyclohexanone Market in Decline
-
Business Society’s Market Outlook for Polyester Staple Fiber on August 14, 2026: Volatile